Impact of conduction disturbances on left ventricular mass regression and geometry change following transcatheter

Tsung-Yu Ko1,2, Hsien-Li Kao3, Ying-Ju Liu4

  • 1Department of Internal Medicine and Cardiovascular Center, National Taiwan University Hospital, Taipei, Taiwan.

Scientific Reports
|August 19, 2021
PubMed

Insights

Transcatheter aortic valve replacement (TAVR) can cause conduction disturbances (CD). Patients without CD after TAVR show improved heart function and sustained LV mass regression over three years, unlike those with CD.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Electrophysiology

Background:

  • Transcatheter aortic valve replacement (TAVR) is a key treatment for aortic stenosis.
  • Conduction disturbances (CD), including new left bundle branch block and permanent pacemaker implantation, are known complications following TAVR.
  • The impact of post-TAVR CD on left ventricular (LV) mass regression and remodeling remains incompletely understood.

Purpose of the Study:

  • To compare left ventricular (LV) mass regression and remodeling in patients with and without conduction disturbances (CD) after transcatheter aortic valve replacement (TAVR).
  • To assess the long-term effects of post-TAVR CD on cardiac structure and function.

Main Methods:

  • Prospective analysis of 152 consecutive TAVR patients.
  • Categorization of patients into groups with and without CD (permanent pacemaker implantation or new left bundle branch block).
  • Evaluation of LV ejection fraction (LVEF), LV end-systolic volume (LVESV), and LV mass index at baseline, 12 months, and 36 months.

Main Results:

  • 53 patients (34.9%) developed CD post-TAVR.
  • At 1-year follow-up, patients without CD showed significant improvement in LVEF and reduced LVESV, whereas patients with CD did not.
  • Both groups exhibited LV mass index decrease at 1 year, but only the non-CD group demonstrated sustained significant LV mass regression at 3 years.

Conclusions:

  • Post-TAVR conduction disturbances are associated with impaired left ventricular remodeling and systolic function recovery.
  • Patients without conduction disturbances following TAVR experience significant LV mass regression at 1 year, with sustained regression observed up to 3 years.
  • These findings highlight the importance of monitoring and managing conduction disturbances after TAVR for optimal cardiac recovery.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
85
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
94
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
84
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
95
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
89
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
61